Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-25-025114
Filing Date
2025-03-18
Accepted
2025-03-18 17:04:23
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm259429-1_424b5.htm 424B5 617668
2 GRAPHIC lg_milestonepharm-4clr.jpg GRAPHIC 27077
3 GRAPHIC lg_milestonepharm-4c.jpg GRAPHIC 39737
  Complete submission text file 0001104659-25-025114.txt   711043
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-283162 | Film No.: 25749368
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)